title: [Adjuvant radioactive gold therapy of primary stage I c ovarian cancer].
abstract: 47 patients with primary ovarian cancer stage I c have been treated following radical operation additionally with an intraperitoneal instillation of 5.5 GBq radioactive gold colloid. 5-year survival rate was 87 per cent. Severe complications have not been observed.
authors.affiliation: Klinik für Gynäkologie und Geburtshilfe, Bereichs Medizin der Wilhelm-Pieck-Universität Rostock.
authors.forename: R
authors.initials: R
authors.lastname: Schwarz
authors.forename: A
authors.initials: A
authors.lastname: Schumacher
mesh_terms: D001918:Brachytherapy / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006048:Gold Colloid, Radioactive / Q000627:therapeutic use*; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D011879:Radiotherapy Dosage
chemical_list: D006048:Gold Colloid, Radioactive
vernacular_title: Adjuvante Radiogoldtherapie des primären Ovarialkarzinoms im Stadium I c.